GMP-Ready Mammalian Cell Line Development Platform

Cell line development is a common bottleneck on the road to IND, with stable cell lines sometimes taking up to a year to produce. This integrated CHO-based platform targets three areas at once: vector design, host cell line, and process. Stable pools generated early, in as little as 3 weeks, let analytical, formulation, and downstream work begin sooner, and tox material supply is decoupled from final cell line selection. The platform is also described across 50L, 500L, and 2,000L scales, along with the analytics and ICH-aligned documentation that support an IND filing. Explore the details to see how timelines, titers, and quality controls fit together.